Octreotide Acetate (79517-01-4) video
Octreotide Acetate (79517-01-4) Description
Octreotide acetate is a potent, long-acting synthetic SOMATOSTATIN octapeptide analog that inhibits secretion of GROWTH HORMONE and is used to treat hormone-secreting tumors; DIABETES MELLITUS; HYPOTENSION, ORTHOSTATIC; HYPERINSULINISM; hypergastrinemia; and small bowel fistula.
Octreotide Acetate is the acetate salt of a synthetic long-acting cyclic octapeptide with pharmacologic properties mimicking those of the natural hormone somatostatin. Octreotide is a more potent inhibitor of growth hormone, glucagon, and insulin than somatostatin. Similar to somatostatin, this agent also suppresses the luteinizing hormone response to gonadotropin-releasing hormone, decreases splanchnic blood flow, and inhibits the release of serotonin, gastrin, vasoactive intestinal peptide (VIP), secretin, motilin, pancreatic polypeptide, and thyroid stimulating hormone.
Octreotide Acetate (79517-01-4) Specifications
|Product Name||Octreotide Acetate|
|Chemical Name||Octreolin; Sandostatin LAR; SMS 201-995 AC; Longastatina
|Molecular Weight||1079.299 g/mol|
|Monoisotopic Mass||1078.462 g/mol|
|Melting Point||>140°C (dec.)|
|Biological Half-Life||100 minutes|
|Color||White to Off-White|
|Solubility||Acetic Acid (Slightly), DMSO (Slightly), Methanol (Slightly)|
|Storage Temperature||-20°C Freezer|
|Application||Octapeptide analog of Somatostatin. A gastric antisecretory agent. Used in treatment of acromegaly.|